X-Genix

X Genix operates at the intersection of synthetic chemistry and synthetic biology, providing advanced tools for molecule access and value creation. The company specializes in the discovery and development of enzymes capable of regioselectively introducing C I, C Br, or C Cl bonds into various molecules, both small and large. X Genix supports its partners from the discovery stages through to development, enhancing research and development processes. The business model revolves around offering patented enzyme solutions that accelerate R&D and optimize manufacturing processes, making them more cost-effective, safer, and sustainable. X Genix serves clients in the chemical and pharmaceutical industries, leveraging its expertise to improve efficiency and innovation in molecule development. The company is recognized for its pioneering research, as evidenced by the prestigious 2022 Corday Morgan Award.

Keywords: synthetic chemistry, synthetic biology, enzyme discovery, molecule development, regioselectivity, R&D acceleration, manufacturing optimization, cost-effective solutions, chemical industry, pharmaceutical industry.